What is the address of BGP-MEDICAL?

The registered office of BGP-MEDICAL is located at Blauwhuisstraat 26, 8020 Oostkamp.

Is BGP-MEDICAL still active?

Yes. According to the CBE (29 October 2026) BGP-MEDICAL is active, legal situation “Normale toestand”, started on 10 November 2021.

Is BGP-MEDICAL registered on Peppol?

Yes, BGP-MEDICAL is registered on the Peppol network with ID 0208:0777254169.

What is the enterprise number of BGP-MEDICAL?

The enterprise number of BGP-MEDICAL is BE0777254169.

When was BGP-MEDICAL founded?

BGP-MEDICAL was founded on 10 November 2021.

Who are the directors of BGP-MEDICAL?

According to the 2025 annual accounts, the directors of BGP-MEDICAL are: Johan Van Havermaet, Xavier Deklerck.

Is BGP-MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 November 2021; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did BGP-MEDICAL make in 2025?

BGP-MEDICAL posted a profit after taxes of € 219 in financial year 2025.

What is the revenue of BGP-MEDICAL?

As a small company, BGP-MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,268.

BGP-MEDICAL (Private Limited) - Oostkamp - BE0777254169

Dossier BGP-MEDICAL, printed on 29 October 2026 from databakkes.be/en/0777254169/bgp-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

BGP-MEDICAL from Oostkamp, company number BE0777254169, closed financial year 2025 with a result of € 219 after tax. For that financial year BGP-MEDICAL recorded a gross margin of € 2,268 and equity of € 2,927. Compared with financial year 2024, the result moved from € -3,434 to € 219. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Growing

€ 2,927

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 219

▲ still € 3,434 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 0

▼ 100% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -7,073.

Debts at end 2025

Bank debt

€ 54

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 7,165

▼ 29% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 525

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 6,018 Gross margin 2022: € 6,018 First fiscal year in the series	€ -7,684 Gross margin 2023: € -7,684 ▼ € 13,702 vs 2022 (€ 6,018) Unfavourable step	€ -2,007 Gross margin 2024: € -2,007 ▲ € 5,677 vs 2023 (€ -7,684) Favourable step	€ 2,268 Gross margin 2025: € 2,268 ▲ € 4,275 vs 2024 (€ -2,007) Favourable step	▲ € 4,275
Profit after taxes	€ 3,925 Profit after taxes 2022: € 3,925 First fiscal year in the series	€ -7,783 Profit after taxes 2023: € -7,783 ▼ € 11,707 vs 2022 (€ 3,925) Unfavourable step	€ -3,434 Profit after taxes 2024: € -3,434 ▲ € 4,349 vs 2023 (€ -7,783) Favourable step	€ 219 Profit after taxes 2025: € 219 ▲ € 3,653 vs 2024 (€ -3,434) Favourable step	▲ € 3,653
Equity	€ 13,925 Equity 2022: € 13,925 First fiscal year in the series	€ 6,142 Equity 2023: € 6,142 ▼ 56% vs 2022 (€ 13,925) Unfavourable step	€ 2,708 Equity 2024: € 2,708 ▼ 56% vs 2023 (€ 6,142) Unfavourable step	€ 2,927 Equity 2025: € 2,927 ▲ 8% vs 2024 (€ 2,708) Favourable step	▲ 8%
Total debts	€ 10,225 Total debts 2022: € 10,225 First fiscal year in the series	€ 9,430 Total debts 2023: € 9,430 ▼ 8% vs 2022 (€ 10,225) Favourable step	€ 10,119 Total debts 2024: € 10,119 ▲ 7% vs 2023 (€ 9,430) Unfavourable step	€ 7,995 Total debts 2025: € 7,995 ▼ 21% vs 2024 (€ 10,119) Favourable step	▼ 21%
Cash	€ 11,672 Cash 2022: € 11,672 First fiscal year in the series	€ 959 Cash 2023: € 959 ▼ 92% vs 2022 (€ 11,672) Unfavourable step	€ 27 Cash 2024: € 27 ▼ 97% vs 2023 (€ 959) Unfavourable step	€ 0 Cash 2025: € 0 ▼ 100% vs 2024 (€ 27) Unfavourable step	▼ 100%
Retained profit	€ 3,925 Retained profit 2022: € 3,925 First fiscal year in the series	€ -3,858 Retained profit 2023: € -3,858 ▼ € 7,783 vs 2022 (€ 3,925) Unfavourable step	€ -7,292 Retained profit 2024: € -7,292 ▼ € 3,434 vs 2023 (€ -3,858) Unfavourable step	€ -7,073 Retained profit 2025: € -7,073 ▲ € 219 vs 2024 (€ -7,292) Favourable step	▲ € 219
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 54 Bank debt 2025: € 54 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 24,150 Balance sheet total 2022: € 24,150 First fiscal year in the series	€ 15,572 Balance sheet total 2023: € 15,572 ▼ 36% vs 2022 (€ 24,150) Unchanged	€ 12,827 Balance sheet total 2024: € 12,827 ▼ 18% vs 2023 (€ 15,572) Unchanged	€ 10,922 Balance sheet total 2025: € 10,922 ▼ 15% vs 2024 (€ 12,827) Unchanged	▼ 15%

Key figures of BGP-MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BGP-MEDICAL?

What happened at BGP-MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: profit of € 219. filed late Source: NBB ↗
Nov 10, 2021 New establishment in Oostkamp. KBO
Nov 10, 2021 Start of the company according to the CBE. KBO
2021 Johan Van Havermaet became a director. NBB
2021 Xavier Deklerck became a director. NBB

In short

From € 3,925 profit in 2022 to € 219 profit in 2025.

Paid € 1,065 in corporate taxes since 2022.

Best year ever: 2022, with € 3,925 profit.

Original PDFs at the National Bank ↗

Management

Johan Van Havermaet Xavier Deklerck

JVHealth

BGP-MEDICAL

SandStone-Medical

DEXAMED

Behind BGP-MEDICAL are Johan Van Havermaet and Xavier Deklerck. Johan Van Havermaet is also behind JVHealth. Xavier Deklerck is also behind SandStone-Medical and DEXAMED.

Directors

According to the 2025 annual accounts

Johan Van Havermaet

Director

Also active at: JVHealth

since 2021

Xavier Deklerck

Director

Also active at: SandStone-Medical, DEXAMED

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Blauwhuisstraat 26

8020 Oostkamp

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

DEXAMED same network

€ 20,983 gross margin · 2025

Endo-Precision

€ -22,507 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0777.254.169
VAT number: BE 0777.254.169
Registered office: Blauwhuisstraat 26, 8020 Oostkamp
Names & denominations: BGP-MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 November 2021
Peppol: Active · Active since 15 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗